BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND PR, PGR, progesterone receptor AND Treatment
660 results:

  • 1. [Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor].
    Lei JY; Li Y; Li CM; Xiong XL; Feng CC; Weng WJ; Peng XM; Zhou DH; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):445-449. PubMed ID: 38660850
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer.
    Huang ML; Lane DL; Bomar H; Kuerer H
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38627044
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case report: A case of Paget disease outside the axillary breast.
    Zhou Z; Zhou B; Wu X; Wei W
    Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal skin Electron Therapy.
    Laughlin BS; Zaniletti I; Foster MG; Lucido J; Mangold AR; Rosenthal AC; VAN DER Walt C; Breen W; Lester S; Hoppe B; Petersen J; Armstrong MD; Bogan A; Rule WG
    Anticancer Res; 2024 Apr; 44(4):1491-1497. PubMed ID: 38537978
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
    Serbest Ceylanoglu K; Guneri Beser B; Singalavanija T; Juntipwong S; Worden FP; Demirci H
    Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):18-29. PubMed ID: 38241616
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.
    Munster P; Iannotti N; Cho DC; Kirkwood JM; Villaruz LC; Gibney GT; Hodi FS; Mettu NB; Jones M; Bowman J; Smith M; Lakshminarayanan M; O'Day S
    Cancer Res Commun; 2023 Dec; 3(12):2572-2584. PubMed ID: 38115208
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With
    Meric-Bernstam F; Rothe M; Mangat PK; Garrett-Mayer E; Gutierrez R; Ahn ER; Cannon TL; Powell S; Krauss JC; Reynolds CM; von Mehren M; Behl D; Calfa CJ; Duvivier HL; Kaplan HG; Livingston MB; Sharma MR; Urba WJ; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
    JCO Precis Oncol; 2023 Sep; 7():e2300385. PubMed ID: 38096472
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nivolumab Plus Ipilimumab in Patients With Solid Tumors With
    Rohatgi N; Rothe M; Mangat PK; Garrett-Mayer E; Meric-Bernstam F; Pisick E; Alese OB; Reynolds CM; Thota R; Vaccaro GM; von Mehren M; Arend RC; Chiu VK; Duvivier HL; Gold PJ; Hack K; Marr AS; Winer A; Grantham GN; Hinshaw DC; Gregory A; Halabi S; Schilsky RL
    JCO Precis Oncol; 2023 Sep; 7():e2300279. PubMed ID: 38039429
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of the safety and feasibility of electrochemotherapy with intravenous bleomycin as local treatment of bladder cancer in dogs.
    Rangel MMM; Linhares LCM; de Oliveira KD; Suzuki DOH; Maglietti FH; de Nardi AB
    Sci Rep; 2023 Nov; 13(1):21078. PubMed ID: 38030630
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
    Hepner A; Versluis JM; Wallace R; Allayous C; Brown LJ; Trojaniello C; Gerard CL; Jansen YJ; Bhave P; Neyns B; Haydon A; Michielin O; Mangana J; Klein O; Shoushtari AN; Warner AB; Ascierto PA; McQuade JL; Carlino MS; Zimmer L; Lebbe C; Johnson DB; Sandhu S; Atkinson V; Blank CU; Lo SN; Long GV; Menzies AM
    Eur J Cancer; 2024 Jan; 196():113441. PubMed ID: 37988842
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
    Maekawa N; Konnai S; Hosoya K; Kim S; Kinoshita R; Deguchi T; Owaki R; Tachibana Y; Yokokawa M; Takeuchi H; Kagawa Y; Takagi S; Ohta H; Kato Y; Yamamoto S; Yamamoto K; Suzuki Y; Okagawa T; Murata S; Ohashi K
    PLoS One; 2023; 18(10):e0291727. PubMed ID: 37792729
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
    Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
    BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. receptor conversion and survival in breast cancer liver metastases.
    Sundén M; Norgren S; Lundqvist R; Andersson A; Sund M; Hemmingsson O
    Breast Cancer Res; 2023 Sep; 25(1):105. PubMed ID: 37705026
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
    Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
    BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.
    Weiss SA; Sznol M; Shaheen M; Berciano-Guerrero MÁ; Couselo EM; Rodríguez-Abreu D; Boni V; Schuchter LM; Gonzalez-Cao M; Arance A; Wei W; Ganti AK; Hauke RJ; Berrocal A; Iannotti NO; Hsu FJ; Kluger HM
    Clin Cancer Res; 2024 Jan; 30(1):74-81. PubMed ID: 37535056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lung cancer with breast metastasis: a case report and review of the literature.
    Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
    J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy.
    De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
    Head Neck; 2023 Sep; 45(9):2363-2368. PubMed ID: 37439379
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence.
    Zhou D; Li M; Xu F; Zheng Q; Lu Q; Hong R; Wang S
    Ann Med; 2023 Dec; 55(1):2232299. PubMed ID: 37431586
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
    Yonekura S; Endo Y; Fujii H; Ishikawa M; Egawa G; Kabashima K
    J Dermatol; 2023 Nov; 50(11):1493-1496. PubMed ID: 37400887
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 33.